1. Home
  2. ICCC vs NAII Comparison

ICCC vs NAII Comparison

Compare ICCC & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • NAII
  • Stock Information
  • Founded
  • ICCC 1982
  • NAII 1980
  • Country
  • ICCC United States
  • NAII United States
  • Employees
  • ICCC N/A
  • NAII N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • NAII Medicinal Chemicals and Botanical Products
  • Sector
  • ICCC Health Care
  • NAII Health Care
  • Exchange
  • ICCC Nasdaq
  • NAII Nasdaq
  • Market Cap
  • ICCC 28.0M
  • NAII 28.0M
  • IPO Year
  • ICCC 1987
  • NAII 1987
  • Fundamental
  • Price
  • ICCC $4.71
  • NAII $4.15
  • Analyst Decision
  • ICCC
  • NAII
  • Analyst Count
  • ICCC 0
  • NAII 0
  • Target Price
  • ICCC N/A
  • NAII N/A
  • AVG Volume (30 Days)
  • ICCC 22.4K
  • NAII 9.7K
  • Earning Date
  • ICCC 11-13-2024
  • NAII 02-11-2025
  • Dividend Yield
  • ICCC N/A
  • NAII N/A
  • EPS Growth
  • ICCC N/A
  • NAII N/A
  • EPS
  • ICCC N/A
  • NAII N/A
  • Revenue
  • ICCC $23,838,001.00
  • NAII $112,977,000.00
  • Revenue This Year
  • ICCC N/A
  • NAII N/A
  • Revenue Next Year
  • ICCC N/A
  • NAII N/A
  • P/E Ratio
  • ICCC N/A
  • NAII N/A
  • Revenue Growth
  • ICCC 46.37
  • NAII N/A
  • 52 Week Low
  • ICCC $3.34
  • NAII $4.02
  • 52 Week High
  • ICCC $5.82
  • NAII $7.26
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 56.95
  • NAII 41.20
  • Support Level
  • ICCC $4.38
  • NAII $4.02
  • Resistance Level
  • ICCC $5.23
  • NAII $4.33
  • Average True Range (ATR)
  • ICCC 0.47
  • NAII 0.15
  • MACD
  • ICCC -0.04
  • NAII -0.01
  • Stochastic Oscillator
  • ICCC 22.92
  • NAII 22.41

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: